Role of lipid peroxidation in the epidemiology and prevention of breast cancer

被引:82
|
作者
Gago-Dominguez, M
Castelao, JE
Pike, MC
Sevanian, A
Haile, RW
机构
[1] Univ So Calif, Keck Sch Med, USC Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90089 USA
[2] Univ So Calif, Keck Sch Med, Sch Pharm, Dept Mol Pharmacol & Toxicol, Los Angeles, CA 90089 USA
基金
美国国家科学基金会;
关键词
D O I
10.1158/1055-9965.EPI-05-0015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have recently proposed a common mechanistic pathway by which obesity and hypertension lead to increased renal cell cancer risk. Our hypothesis posits lipid peroxidation, which is a principal mechanism in rodent renal carcinogenesis, as an intermediate step that leads to a final common pathway shared by numerous observed risks (including obesity, hypertension, smoking, oophorectomy/hysterectomy, parity, preeclampsia, diabetes, and analgesics) or protective factors (including oral contraceptive use and alcohol) for renal cell cancer [Cancer Causes Control 2002;13:287-93]. During this exercise, we have noticed how certain risk factors for renal cell carcinoma are protective for breast cancer and how certain protective factors for renal cell carcinoma increase risk for breast cancer. Parity and oophorectomy, for example, are positively associated with renal cell carcinoma but are negatively associated with breast cancer. Similarly, obesity and hypertension are positively associated with renal cell carcinoma, but obesity is negatively associated with breast cancer in premenopausal women and hypertension during pregnancy is negatively associated with breast cancer. Furthermore, alcohol intake, negatively associated with renal cell carcinoma, is also positively associated with breast cancer. We propose here the possibility that lipid peroxidation may represent a protective mechanism in breast cancer. Although this runs counter to the conventional view that lipid peroxidation is a process that is harmful and carcinogenic, we present here the chemical and biological rationale, based on epidemiologic and biochemical data, which may deserve further consideration and investigation.
引用
收藏
页码:2829 / 2839
页数:11
相关论文
共 50 条
  • [1] The lipid peroxidation in breast cancer patients
    Kedzierska, Magdalena
    Olas, Beata
    Wachowicz, Barbara
    Jeziorski, Arkadiusz
    Piekarski, Janusz
    [J]. GENERAL PHYSIOLOGY AND BIOPHYSICS, 2010, 29 (02) : 208 - 210
  • [2] THE POSSIBLE ROLE OF LIPID-PEROXIDATION IN BREAST-CANCER RISK
    BOYD, NF
    MCGUIRE, V
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 1991, 10 (3-4) : 185 - 190
  • [3] IS THERE A SIGNIFICANT ROLE FOR LIPID-PEROXIDATION IN THE CAUSATION OF MALIGNANCY AND FOR ANTIOXIDANTS IN CANCER PREVENTION
    DIPLOCK, AT
    RICEEVANS, CA
    BURDON, RH
    [J]. CANCER RESEARCH, 1994, 54 (07) : S1952 - S1956
  • [4] THE ROLE OF ESTROGENS AND PROGESTAGENS IN THE EPIDEMIOLOGY AND PREVENTION OF BREAST-CANCER
    KEY, TJA
    PIKE, MC
    [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (01): : 29 - 43
  • [5] Epidemiology and prevention of breast cancer
    Lagiou, A.
    [J]. ARCHIVES OF HELLENIC MEDICINE, 2008, 25 (06): : 742 - 748
  • [6] Epidemiology and prevention of breast cancer
    Colditz, GA
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (04) : 768 - 772
  • [7] Epidemiology and prevention of breast cancer
    Kelsey, JL
    Bernstein, L
    [J]. ANNUAL REVIEW OF PUBLIC HEALTH, 1996, 17 : 47 - 67
  • [8] The role of epidemiology in cancer prevention
    Oliveria, SA
    Christos, PJ
    Berwick, M
    [J]. PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1997, 216 (02): : 142 - 150
  • [9] Breast Cancer Epidemiology, Prevention, and Screening
    Winters, Stella
    Martin, Charmaine
    Murphy, Daniel
    Shokar, Navkiran K.
    [J]. APPROACHES TO UNDERSTANDING BREAST CANCER, 2017, 151 : 1 - 32
  • [10] Role of lipid peroxidation and oxidative stress in the association between thyroid diseases and breast cancer
    Gago-Dominguez, Manuela
    Castelao, Jose Esteban
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2008, 68 (02) : 107 - 114